RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Analyte monitoring device and methods of use

  • US 8,622,906 B2
  • Filed: 12/21/2009
  • Issued: 01/07/2014
  • Est. Priority Date: 04/30/1998
  • Status: Expired due to Term
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save